Survival outcomes after neoadjuvant letrozole and palbociclib versus third generation chemotherapy for patients with high-risk oestrogen receptor-positive HER2-negative breast cancer.

Autor: Delaloge S; Department of Cancer Medicine, Gustave Roussy, Villejuif, France. Electronic address: suzette.delaloge@gustaveroussy.fr., Dureau S; Department of Biostatistics, Institut Curie, Paris, France., D'Hondt V; Department of Medical Oncology, Institut du Cancer Montpellier, Montpellier, France., Desmoulins I; Department of Medical Oncology, Centre Georges François Leclerc, Dijon, France., Heudel PE; Department of Medical Oncology, Centre Leon Berard, Lyon, France., Duhoux FP; Department of Medical Oncology, Cliniques Universitaires Saint-Luc, Brussels, Belgium., Levy C; Department of Medical Oncology, Centre François Baclesse, Caen, France., Lerebours F; Department of Medical Oncology, Curie Institute, Saint Cloud, France., Mouret-Reynier MA; Department of Medical Oncology, Centre Jean Perrin, Clermont Ferrand, France., Dalenc F; Department of Medical Oncology, Institut Claudius Regaud, IUCT-Oncopole, Toulouse, France., Frenel JS; Department of Medical Oncology, Institut de Cancérologie de l'Ouest, Nantes, France., Jouannaud C; Department of Medical Oncology, Institut Godinot, Reims, France., Venat-Bouvet L; Department of Medical Oncology, CHU Limoges, Limoges, France., Nguyen S; Medical Oncology, Centre Hospitalier de Pau, Pau, France., Callens C; Research Centre, Department of Translational Research, Genomics Platform, Institut Curie, Paris Sciences et Lettres Research University, Paris, France., Gentien D; Research Centre, Department of Translational Research, Genomics Platform, Institut Curie, Paris Sciences et Lettres Research University, Paris, France., Rapinat A; Research Centre, Department of Translational Research, Genomics Platform, Institut Curie, Paris Sciences et Lettres Research University, Paris, France., Manduzio H; R&D Unicancer, Paris, France., Vincent-Salomon A; Research Centre, Department of Translational Research, Genomics Platform, Institut Curie, Paris Sciences et Lettres Research University, Paris, France., Lemonnier J; R&D Unicancer, Paris, France., Cottu P; Department of Medical Oncology, Institut Curie & PSL University, Paris, France.

Publikováno v: European journal of cancer (Oxford, England : 1990) [Eur J Cancer] 2022 May; Vol. 166, pp. 300-308. Date of Electronic Publication: 2022 Mar 22.

Dose-Dense Methotrexate, Vinblastine, Doxorubicin, and Cisplatin With or Without Panitumumab in Patients With Advanced Urothelial Carcinoma: Multicenter, Randomized, French Unicancer GETUG/AFU 19 Study.

Autor: Culine S; Department of Medical Oncology Saint-Louis University Hospital, AP-HP, Paris, France. Electronic address: stephane.culine@aphp.fr., Fléchon A; Department of Medical Oncology, Léon Bérard Cancer Center, Lyon, France., Gravis G; Department of Medical Oncology, Paoli Calmettes Institute, Marseille, France., Roubaud G; Department of Medical Oncology, Bergonié Institute, Bordeaux, France., Loriot Y; Department of Cancer Medicine, Gustave Roussy, Inserm U981, Villejuif, France., Joly F; Department of Medical Oncology, François Baclesse Cancer Center, Caen, France., Barthélémy P; Department of Medical Oncology, University Hospital, Strasbourg, France., Assaf E; Department of Medical Oncology, Henri Mondor University Hospital, AP-HP, Créteil, France., Mahammedi H; Department of Medical Oncology, Jean Perrin Cancer Center, Clermont-Ferrand, France., Beuzeboc P; Department of Medical Oncology, Curie Institute, Paris, France., Houédé N; Gard Cancer Institute, University Hospital, Nîmes, Inserm U1194, Montpellier Cancer Institute, University of Montpellier, Montpellier, France., Rolland F; Department of Medical Oncology, René Gauducheau Cancer Center, Nantes, France., Guillot A; Department of Medical Oncology, Lucien Neuwirth Cancer Institute, Saint-Priest-en-Jarez, France., Gross-Goupil M; Department of Medical Oncology, University Hospital, Bordeaux, France., Spano JP; Department of Medical Oncology, Pitié-Salpétrière University Hospital, AP-HP, Paris, France., Tartas S; Department of Medical Oncology, Lyon-Sud University Hospital, Lyon, France., Deblock M; Department of Medical Oncology, Alexis Vautrin Cancer Center, Nancy, France., Chevreau C; Department of Medical Oncology, ICR-IUCT Oncopole, Toulouse, France., Serrate C; Department of Medical Oncology, Diaconesses Croix Saint-Simon Hospital, Paris, France., Manduzio H; Unicancer, Paris, France., Habibian M; Unicancer, Paris, France., Thézénas S; Department of Biostatistics, Montpellier Cancer Institute, Montpellier, France., Allory Y; Department of Pathology, René Huguenin Curie Institute, Saint Cloud, France.

Publikováno v: Clinical genitourinary cancer [Clin Genitourin Cancer] 2021 Aug; Vol. 19 (4), pp. e216-e222. Date of Electronic Publication: 2021 Feb 24.

Evidence for relationships between enzymatic biomarker responses and pollution loads in mussel species collected along a pollution gradient

Autor: Rocher, B., Manduzio, H., Geffard, Olivier, Le Ménach, K., Peluhet, L., Augagneur, S., Pottier, D., Leboulanger, F., Budzinski, H., Cachot, J.

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od_______166::b97f245488c3f5a08521b8372bcd317f
https://hal.archives-ouvertes.fr/hal-00081337

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.